العربية
English Indonesia Türkçe Deutsch Español Português Pусский Français Italiano Nederlands Polski العربية ไทย Tiếng Việt 繁體中文 简体中文 日本語 한국어

#monarch2 نتائج البحث

VukovicPetra's profile picture. Medical Oncologist
pvukovic
 @VukovicPetra
١٤ أكتوبر ٢٠٢٠ م

👀 on @OncJournal ➡️ #Safety analysis of #MONARCH2 & #MONARCH3 & management of abemaciclib-associated adverse events ➡️ PFS benefit of abemaciclib was not impacted by dose reductions or early onset of toxicities #Oncoalert theoncologist.onlinelibrary.wiley.com/doi/full/10.10…

VukovicPetra's tweet image. 👀 on @OncJournal ➡️ #Safety analysis of #MONARCH2 & #MONARCH3 & management of abemaciclib-associated adverse events ➡️ PFS benefit of abemaciclib was not impacted by dose reductions or early onset of toxicities #Oncoalert theoncologist.onlinelibrary.wiley.com/doi/full/10.10…
VukovicPetra's tweet image. 👀 on @OncJournal ➡️ #Safety analysis of #MONARCH2 & #MONARCH3 & management of abemaciclib-associated adverse events ➡️ PFS benefit of abemaciclib was not impacted by dose reductions or early onset of toxicities #Oncoalert theoncologist.onlinelibrary.wiley.com/doi/full/10.10…
0
14
29
5
0
KhadafyKhan's profile picture. Trombonist, Composer, Arranger, Dorico, Cubase & Traktor Pro Expert, DJ
Khadafy Khan
 @KhadafyKhan
١٨ مايو ٢٠٢٢ م

Let's try these IEM out for a little bit. #monarch2

KhadafyKhan's tweet image. Let's try these IEM out for a little bit. #monarch2
KhadafyKhan's tweet image. Let's try these IEM out for a little bit. #monarch2
KhadafyKhan's tweet image. Let's try these IEM out for a little bit. #monarch2
0
0
0
0
0
andijadmiko's profile picture.
Andi J
 @andijadmiko
٢٩ مارس ٢٠١٥ م

Cukup luangkan 45 menit waktu libur untuk melemaskan kaki dengan bersepeda.. (w/ @Polygonbike #Monarch2)

andijadmiko's tweet image. Cukup luangkan 45 menit waktu libur untuk melemaskan kaki dengan bersepeda.. (w/ @Polygonbike #Monarch2)
0
0
0
0
0
matteolambe's profile picture. Associate Professor at @UniGenova & Medical Oncologist at @SanMartino_Ge. Chair of @myESMO YOC. #BreastCancer #Fertility. Big fan of @sampdoria & @giroditalia.
Matteo Lambertini, MD PhD
 @matteolambe
٢٩ سبتمبر ٢٠١٩ م

#ESMO19 Presidential Session abstract 1 - updated results from #MONARCH2: significant improvement in overall survival with the addition of #abemaciclib to #fulvestrant in advanced endocrine resistant HR+/HER2- #BreastCancer #bcsm #OncoAlert @OncoAlert @myESMO

matteolambe's tweet image. #ESMO19 Presidential Session abstract 1 - updated results from #MONARCH2: significant improvement in overall survival with the addition of #abemaciclib to #fulvestrant in advanced endocrine resistant HR+/HER2- #BreastCancer #bcsm #OncoAlert @OncoAlert @myESMO
matteolambe's tweet image. #ESMO19 Presidential Session abstract 1 - updated results from #MONARCH2: significant improvement in overall survival with the addition of #abemaciclib to #fulvestrant in advanced endocrine resistant HR+/HER2- #BreastCancer #bcsm #OncoAlert @OncoAlert @myESMO
matteolambe's tweet image. #ESMO19 Presidential Session abstract 1 - updated results from #MONARCH2: significant improvement in overall survival with the addition of #abemaciclib to #fulvestrant in advanced endocrine resistant HR+/HER2- #BreastCancer #bcsm #OncoAlert @OncoAlert @myESMO
matteolambe's tweet image. #ESMO19 Presidential Session abstract 1 - updated results from #MONARCH2: significant improvement in overall survival with the addition of #abemaciclib to #fulvestrant in advanced endocrine resistant HR+/HER2- #BreastCancer #bcsm #OncoAlert @OncoAlert @myESMO
0
12
34
1
0
Sequans's profile picture. Pioneer in Bitcoin Treasury | Leading provider of IoT semiconductor solutions | $SQNS
Sequans
 @Sequans
١٧ فبراير ٢٠٢٢ م

As the world's first Common Criteria EAL5+ certified cellular IoT platform, Monarch 2 is leading the way to the iSIM era. See it at MWC 2022. sequans.com/meet-us-in-bar… #cellulariot #monarch2 #iSIM sequans.com/press-release/…

Sequans's tweet image. As the world's first Common Criteria EAL5+ certified cellular IoT platform, Monarch 2 is leading the way to the iSIM era. See it at MWC 2022. sequans.com/meet-us-in-bar… #cellulariot #monarch2 #iSIM sequans.com/press-release/…
0
0
1
0
0
RollecateGroep's profile picture. Als het om gevels gaat! Ook te volgen op facebook: https://t.co/6LHb31o2hB
Rollecate
 @RollecateGroep
١٢ أغسطس ٢٠١٣ م

Statusupdate project #Monarch2 te #DenHaag. Indrukwekkend project met een mooie gevel.

RollecateGroep's tweet image. Statusupdate project #Monarch2 te #DenHaag. Indrukwekkend project met een mooie gevel.
0
0
0
0
0
RollecateGroep's profile picture. Als het om gevels gaat! Ook te volgen op facebook: https://t.co/6LHb31o2hB
Rollecate
 @RollecateGroep
٢٩ أكتوبر ٢٠١٣ م

@BAMGroep_NL Gefeliciteerd met jullie nieuwe kantoor! #Monarch2 Trots dat wij een bijdrage hebben mogen leveren!

RollecateGroep's tweet image. @BAMGroep_NL Gefeliciteerd met jullie nieuwe kantoor! #Monarch2 Trots dat wij een bijdrage hebben mogen leveren!
0
0
0
0
0
marga_nfk's profile picture. Projectleider @nfkkanker Patiëntenplatform Zeldzame Kankers. Passie voor het verbeteren van kwaliteit van zorg vanuit patientenperspectief.
marga_nfk
 @marga_nfk
٣ يونيو ٢٠١٧ م

#monarch2. Dr Sledge. Abemaciclib in combinatie met fulvestrant bij pat met uitgezaaide hr+/her2- progressie op endocriene therapie

marga_nfk's tweet image. #monarch2. Dr Sledge. Abemaciclib in combinatie met fulvestrant bij pat met uitgezaaide hr+/her2- progressie op endocriene therapie
0
0
0
0
0
SCIDirector's profile picture. Stanford University medical oncologist and cancer scientist, and Director of the Stanford Cancer Institute. Follows and retweets are not endorsements.
Steven Artandi, MD, PhD
 @SCIDirector
٣٠ سبتمبر ٢٠١٩ م

SCI Program Leader George Sledge found that two targeted treatments can extend the lifespan and delay the need for chemotherapy in women with HER2-negative metastatic #breastcancer. stan.md/2mnqtwF #bcsm #monarch2 @GeorgeSledge51

SCIDirector's tweet image. SCI Program Leader George Sledge found that two targeted treatments can extend the lifespan and delay the need for chemotherapy in women with HER2-negative metastatic #breastcancer. stan.md/2mnqtwF #bcsm #monarch2 @GeorgeSledge51
0
1
7
0
0
iMrShashikant's profile picture. Movies And Technology. • iMrShashikant
Shashikant Puri
 @iMrShashikant
١١ أبريل ٢٠٢٤ م

#Monarch2

HollywoodHandle's profile picture. Welcome to The Hollywood Handle! Updates, News, Reviews, and Much More! 📩: ricardoaymar@thehollywoodhandle.co
The Hollywood Handle
@HollywoodHandle
١١ أبريل ٢٠٢٤ م

‘MONARCH: LEGACY OF MONSTERS’ has been renewed for Season 2 at Apple.

HollywoodHandle's tweet image. ‘MONARCH: LEGACY OF MONSTERS’ has been renewed for Season 2 at Apple.
27
138
1ألف
47
32ألف
0
0
1
0
17
demattosarruda's profile picture. Senior Director Global Clinical Development @BioNTech_Group, Medical Oncologist,Physician-scientist, Past VHIO IRSI #immunotherapy #precisionmedicine ViewsMine
Leticia De Mattos-Ar
 @demattosarruda
٢٩ سبتمبر ٢٠١٩ م

Presidential session now: Monarch2 OS: 46 vs 37 m, fulvestran + or - abemaciclib —> median OS 9.4 months of benefit #ESMO19 #breastcancer #monarch2

demattosarruda's tweet image. Presidential session now: Monarch2 OS: 46 vs 37 m, fulvestran + or - abemaciclib —> median OS 9.4 months of benefit #ESMO19 #breastcancer #monarch2
0
1
4
0
0
Sequans's profile picture. Pioneer in Bitcoin Treasury | Leading provider of IoT semiconductor solutions | $SQNS
Sequans
 @Sequans
٦ مارس ٢٠١٩ م

See our new video introducing Monarch 2, the world's most advanced LTE-M/NB-IoT chip: youtube.com/watch?v=AfJZmr… #lteforiot #monarch2

0
3
6
0
0
ecancer's profile picture. ecancer is a charity with a mission to raise the standards of care for cancer patients across the world through education. #openaccess
ecancer
 @ecancer
٣١ يوليو ٢٠١٩ م

#Abemaciclib significantly extended life in women with hormone receptor-positive, HER2-negative advanced #breastcancer. Read more here: bit.ly/2Kc5THA #MONARCH2 #TargetedTherapy #OverallSurvival #Oncology

ecancer's tweet image. #Abemaciclib significantly extended life in women with hormone receptor-positive, HER2-negative advanced #breastcancer. Read more here: bit.ly/2Kc5THA #MONARCH2 #TargetedTherapy #OverallSurvival #Oncology
1
1
1
0
0
superchecco's profile picture. HORROR MOVIES WILL SAVE THE WORLD!!!🏳️‍🌈🎃
FRANCESCO FALCIANI 🏳️‍🌈
 @superchecco
١٢ أبريل ٢٠٢٤ م

I just they can confirm a new movie too... I know I should be already happy with #Monarch2 but you know... fans life

1
0
1
0
518
LeCancerFr's profile picture. le #CANCER.fr site d'#ACTUALITÉ #santé scientifique en #ONCOLOGIE. #MÉDECINE #CLCC #CHU #CONGRÈS #CHIMIOTHÉRAPIE #IMMUNOTHÉRAPIE #oncology #ASCO #SABCS #ESMO
LeCancer.fr
@LeCancerFr
٤ يونيو ٢٠١٧ م

#ASCO2017 #SEIN #MONARCH2 #Resultats Arrivée de l’abemaciclib en combinaison au fulvestrant dans les cancers ... - bit.ly/2rSnbTe

LeCancerFr's tweet image. #ASCO2017 #SEIN #MONARCH2 #Resultats Arrivée de l’abemaciclib en combinaison au fulvestrant dans les cancers ... - bit.ly/2rSnbTe
0
0
1
0
0
superchecco's profile picture. HORROR MOVIES WILL SAVE THE WORLD!!!🏳️‍🌈🎃
FRANCESCO FALCIANI 🏳️‍🌈
 @superchecco
١٢ أبريل ٢٠٢٤ م

I just they can confirm a new movie too... I know I should be already happy with #Monarch2 but you know... fans life

1
0
1
0
518
iMrShashikant's profile picture. Movies And Technology. • iMrShashikant
Shashikant Puri
 @iMrShashikant
١١ أبريل ٢٠٢٤ م

#Monarch2

HollywoodHandle's profile picture. Welcome to The Hollywood Handle! Updates, News, Reviews, and Much More! 📩: ricardoaymar@thehollywoodhandle.co
The Hollywood Handle
@HollywoodHandle
١١ أبريل ٢٠٢٤ م

‘MONARCH: LEGACY OF MONSTERS’ has been renewed for Season 2 at Apple.

HollywoodHandle's tweet image. ‘MONARCH: LEGACY OF MONSTERS’ has been renewed for Season 2 at Apple.
27
138
1ألف
47
32ألف
0
0
1
0
17
IfeIngram's profile picture. 6’7”| Wing ifeanasbinmalik@gmail.com
Ife West-Ingram
 @IfeIngram
٤ نوفمبر ٢٠٢٢ م

Iayze top 1 in the underground and it ain’t even close #monarch2

0
0
1
0
0
KhadafyKhan's profile picture. Trombonist, Composer, Arranger, Dorico, Cubase & Traktor Pro Expert, DJ
Khadafy Khan
 @KhadafyKhan
١٨ مايو ٢٠٢٢ م

Let's try these IEM out for a little bit. #monarch2

KhadafyKhan's tweet image. Let's try these IEM out for a little bit. #monarch2
KhadafyKhan's tweet image. Let's try these IEM out for a little bit. #monarch2
KhadafyKhan's tweet image. Let's try these IEM out for a little bit. #monarch2
0
0
0
0
0
Sequans's profile picture. Pioneer in Bitcoin Treasury | Leading provider of IoT semiconductor solutions | $SQNS
Sequans
 @Sequans
١٧ فبراير ٢٠٢٢ م

As the world's first Common Criteria EAL5+ certified cellular IoT platform, Monarch 2 is leading the way to the iSIM era. See it at MWC 2022. sequans.com/meet-us-in-bar… #cellulariot #monarch2 #iSIM sequans.com/press-release/…

Sequans's tweet image. As the world's first Common Criteria EAL5+ certified cellular IoT platform, Monarch 2 is leading the way to the iSIM era. See it at MWC 2022. sequans.com/meet-us-in-bar… #cellulariot #monarch2 #iSIM sequans.com/press-release/…
0
0
1
0
0
FernandoOnco's profile picture. Apaixonado por oncologia. Compartilho novidades na área Siga para insights e conversas! Câncer de mama, câncer de pulmão, pesquisa clínica, AI, inovação
Jose Fernando Moura, PhD
@FernandoOnco
٥ فبراير ٢٠٢٢ م

@OncoAlert #monarch2 trial shows ⬆️PFS and ⬆️OS

PTarantinoMD's profile picture. MD, PhD, Medical Oncologist | Clinical Fellow @DanaFarber | @Harvard. Associate Editor @ESMO_Open. Interested in breast oncology, HER2, ADCs and good music.
Paolo Tarantino
@PTarantinoMD
٥ فبراير ٢٠٢٢ م

Reassuring ctDNA analysis from #MONARCH2, led by @stolaney1 & now published on @CCR_AACR The addition of abema to fulvestrant improved PFS and OS regardless of ctDNA-detected PIK3CA or ESR1 mutational status, with greater PFS improvement in mutant cases clincancerres.aacrjournals.org/content/early/…

1
21
55
7
0
0
0
0
0
0
PTarantinoMD's profile picture. MD, PhD, Medical Oncologist | Clinical Fellow @DanaFarber | @Harvard. Associate Editor @ESMO_Open. Interested in breast oncology, HER2, ADCs and good music.
Paolo Tarantino
@PTarantinoMD
٥ فبراير ٢٠٢٢ م

Reassuring ctDNA analysis from #MONARCH2, led by @stolaney1 & now published on @CCR_AACR The addition of abema to fulvestrant improved PFS and OS regardless of ctDNA-detected PIK3CA or ESR1 mutational status, with greater PFS improvement in mutant cases clincancerres.aacrjournals.org/content/early/…

1
21
55
7
0
VukovicPetra's profile picture. Medical Oncologist
pvukovic
 @VukovicPetra
١٤ أكتوبر ٢٠٢٠ م

👀 on @OncJournal ➡️ #Safety analysis of #MONARCH2 & #MONARCH3 & management of abemaciclib-associated adverse events ➡️ PFS benefit of abemaciclib was not impacted by dose reductions or early onset of toxicities #Oncoalert theoncologist.onlinelibrary.wiley.com/doi/full/10.10…

VukovicPetra's tweet image. 👀 on @OncJournal ➡️ #Safety analysis of #MONARCH2 & #MONARCH3 & management of abemaciclib-associated adverse events ➡️ PFS benefit of abemaciclib was not impacted by dose reductions or early onset of toxicities #Oncoalert theoncologist.onlinelibrary.wiley.com/doi/full/10.10…
VukovicPetra's tweet image. 👀 on @OncJournal ➡️ #Safety analysis of #MONARCH2 & #MONARCH3 & management of abemaciclib-associated adverse events ➡️ PFS benefit of abemaciclib was not impacted by dose reductions or early onset of toxicities #Oncoalert theoncologist.onlinelibrary.wiley.com/doi/full/10.10…
0
14
29
5
0
SCIDirector's profile picture. Stanford University medical oncologist and cancer scientist, and Director of the Stanford Cancer Institute. Follows and retweets are not endorsements.
Steven Artandi, MD, PhD
 @SCIDirector
٣٠ سبتمبر ٢٠١٩ م

SCI Program Leader George Sledge found that two targeted treatments can extend the lifespan and delay the need for chemotherapy in women with HER2-negative metastatic #breastcancer. stan.md/2mnqtwF #bcsm #monarch2 @GeorgeSledge51

SCIDirector's tweet image. SCI Program Leader George Sledge found that two targeted treatments can extend the lifespan and delay the need for chemotherapy in women with HER2-negative metastatic #breastcancer. stan.md/2mnqtwF #bcsm #monarch2 @GeorgeSledge51
0
1
7
0
0
medwireNews's profile picture. medwireNews is an independent online medical news service.
medwireNews
 @medwireNews
٣٠ سبتمبر ٢٠١٩ م

#ESMO19 video: George Sledge @GeorgeSledge51 talks to us about positive overall survival data from the #MONARCH2 trial involving the addition of #abenaciclib to #fulvestrant in metastatic #breastcancer @Stanford bit.ly/2mQSygh

0
0
1
0
0
alexyazigi's profile picture. Surgical Oncologist, MD & General surgeon @chdax #sarcoma #carcinosis #ovariancancer #PDAC #colorectalcancer Views are my own #Rugby 🏉
Alexandre Yazigi
 @alexyazigi
٢٩ سبتمبر ٢٠١٩ م

#MONARCH2: median OS of 46.7 months for abemaciclib plus fulvestrant and 37.3 months for placebo plus fulvestrant (hazard ratio [HR], 0.757; 95% CI, 0.606-0.945; P = .01) | #BreastCancer | JAMA Oncology jamanetwork.com/journals/jamao…

0
1
0
0
0
VukovicPetra's profile picture. Medical Oncologist
pvukovic
 @VukovicPetra
١٤ أكتوبر ٢٠٢٠ م

👀 on @OncJournal ➡️ #Safety analysis of #MONARCH2 & #MONARCH3 & management of abemaciclib-associated adverse events ➡️ PFS benefit of abemaciclib was not impacted by dose reductions or early onset of toxicities #Oncoalert theoncologist.onlinelibrary.wiley.com/doi/full/10.10…

VukovicPetra's tweet image. 👀 on @OncJournal ➡️ #Safety analysis of #MONARCH2 & #MONARCH3 & management of abemaciclib-associated adverse events ➡️ PFS benefit of abemaciclib was not impacted by dose reductions or early onset of toxicities #Oncoalert theoncologist.onlinelibrary.wiley.com/doi/full/10.10…
VukovicPetra's tweet image. 👀 on @OncJournal ➡️ #Safety analysis of #MONARCH2 & #MONARCH3 & management of abemaciclib-associated adverse events ➡️ PFS benefit of abemaciclib was not impacted by dose reductions or early onset of toxicities #Oncoalert theoncologist.onlinelibrary.wiley.com/doi/full/10.10…
0
14
29
5
0
KhadafyKhan's profile picture. Trombonist, Composer, Arranger, Dorico, Cubase & Traktor Pro Expert, DJ
Khadafy Khan
 @KhadafyKhan
١٨ مايو ٢٠٢٢ م

Let's try these IEM out for a little bit. #monarch2

KhadafyKhan's tweet image. Let's try these IEM out for a little bit. #monarch2
KhadafyKhan's tweet image. Let's try these IEM out for a little bit. #monarch2
KhadafyKhan's tweet image. Let's try these IEM out for a little bit. #monarch2
0
0
0
0
0
matteolambe's profile picture. Associate Professor at @UniGenova & Medical Oncologist at @SanMartino_Ge. Chair of @myESMO YOC. #BreastCancer #Fertility. Big fan of @sampdoria & @giroditalia.
Matteo Lambertini, MD PhD
 @matteolambe
٢٩ سبتمبر ٢٠١٩ م

#ESMO19 Presidential Session abstract 1 - updated results from #MONARCH2: significant improvement in overall survival with the addition of #abemaciclib to #fulvestrant in advanced endocrine resistant HR+/HER2- #BreastCancer #bcsm #OncoAlert @OncoAlert @myESMO

matteolambe's tweet image. #ESMO19 Presidential Session abstract 1 - updated results from #MONARCH2: significant improvement in overall survival with the addition of #abemaciclib to #fulvestrant in advanced endocrine resistant HR+/HER2- #BreastCancer #bcsm #OncoAlert @OncoAlert @myESMO
matteolambe's tweet image. #ESMO19 Presidential Session abstract 1 - updated results from #MONARCH2: significant improvement in overall survival with the addition of #abemaciclib to #fulvestrant in advanced endocrine resistant HR+/HER2- #BreastCancer #bcsm #OncoAlert @OncoAlert @myESMO
matteolambe's tweet image. #ESMO19 Presidential Session abstract 1 - updated results from #MONARCH2: significant improvement in overall survival with the addition of #abemaciclib to #fulvestrant in advanced endocrine resistant HR+/HER2- #BreastCancer #bcsm #OncoAlert @OncoAlert @myESMO
matteolambe's tweet image. #ESMO19 Presidential Session abstract 1 - updated results from #MONARCH2: significant improvement in overall survival with the addition of #abemaciclib to #fulvestrant in advanced endocrine resistant HR+/HER2- #BreastCancer #bcsm #OncoAlert @OncoAlert @myESMO
0
12
34
1
0
RollecateGroep's profile picture. Als het om gevels gaat! Ook te volgen op facebook: https://t.co/6LHb31o2hB
Rollecate
 @RollecateGroep
١٢ أغسطس ٢٠١٣ م

Statusupdate project #Monarch2 te #DenHaag. Indrukwekkend project met een mooie gevel.

RollecateGroep's tweet image. Statusupdate project #Monarch2 te #DenHaag. Indrukwekkend project met een mooie gevel.
0
0
0
0
0
andijadmiko's profile picture.
Andi J
 @andijadmiko
٢٩ مارس ٢٠١٥ م

Cukup luangkan 45 menit waktu libur untuk melemaskan kaki dengan bersepeda.. (w/ @Polygonbike #Monarch2)

andijadmiko's tweet image. Cukup luangkan 45 menit waktu libur untuk melemaskan kaki dengan bersepeda.. (w/ @Polygonbike #Monarch2)
0
0
0
0
0
RollecateGroep's profile picture. Als het om gevels gaat! Ook te volgen op facebook: https://t.co/6LHb31o2hB
Rollecate
 @RollecateGroep
٢٩ أكتوبر ٢٠١٣ م

@BAMGroep_NL Gefeliciteerd met jullie nieuwe kantoor! #Monarch2 Trots dat wij een bijdrage hebben mogen leveren!

RollecateGroep's tweet image. @BAMGroep_NL Gefeliciteerd met jullie nieuwe kantoor! #Monarch2 Trots dat wij een bijdrage hebben mogen leveren!
0
0
0
0
0
SCIDirector's profile picture. Stanford University medical oncologist and cancer scientist, and Director of the Stanford Cancer Institute. Follows and retweets are not endorsements.
Steven Artandi, MD, PhD
 @SCIDirector
٣٠ سبتمبر ٢٠١٩ م

SCI Program Leader George Sledge found that two targeted treatments can extend the lifespan and delay the need for chemotherapy in women with HER2-negative metastatic #breastcancer. stan.md/2mnqtwF #bcsm #monarch2 @GeorgeSledge51

SCIDirector's tweet image. SCI Program Leader George Sledge found that two targeted treatments can extend the lifespan and delay the need for chemotherapy in women with HER2-negative metastatic #breastcancer. stan.md/2mnqtwF #bcsm #monarch2 @GeorgeSledge51
0
1
7
0
0
Sequans's profile picture. Pioneer in Bitcoin Treasury | Leading provider of IoT semiconductor solutions | $SQNS
Sequans
 @Sequans
١٧ فبراير ٢٠٢٢ م

As the world's first Common Criteria EAL5+ certified cellular IoT platform, Monarch 2 is leading the way to the iSIM era. See it at MWC 2022. sequans.com/meet-us-in-bar… #cellulariot #monarch2 #iSIM sequans.com/press-release/…

Sequans's tweet image. As the world's first Common Criteria EAL5+ certified cellular IoT platform, Monarch 2 is leading the way to the iSIM era. See it at MWC 2022. sequans.com/meet-us-in-bar… #cellulariot #monarch2 #iSIM sequans.com/press-release/…
0
0
1
0
0
marga_nfk's profile picture. Projectleider @nfkkanker Patiëntenplatform Zeldzame Kankers. Passie voor het verbeteren van kwaliteit van zorg vanuit patientenperspectief.
marga_nfk
 @marga_nfk
٣ يونيو ٢٠١٧ م

#monarch2. Dr Sledge. Abemaciclib in combinatie met fulvestrant bij pat met uitgezaaide hr+/her2- progressie op endocriene therapie

marga_nfk's tweet image. #monarch2. Dr Sledge. Abemaciclib in combinatie met fulvestrant bij pat met uitgezaaide hr+/her2- progressie op endocriene therapie
0
0
0
0
0
ecancer's profile picture. ecancer is a charity with a mission to raise the standards of care for cancer patients across the world through education. #openaccess
ecancer
 @ecancer
٣١ يوليو ٢٠١٩ م

#Abemaciclib significantly extended life in women with hormone receptor-positive, HER2-negative advanced #breastcancer. Read more here: bit.ly/2Kc5THA #MONARCH2 #TargetedTherapy #OverallSurvival #Oncology

ecancer's tweet image. #Abemaciclib significantly extended life in women with hormone receptor-positive, HER2-negative advanced #breastcancer. Read more here: bit.ly/2Kc5THA #MONARCH2 #TargetedTherapy #OverallSurvival #Oncology
1
1
1
0
0
demattosarruda's profile picture. Senior Director Global Clinical Development @BioNTech_Group, Medical Oncologist,Physician-scientist, Past VHIO IRSI #immunotherapy #precisionmedicine ViewsMine
Leticia De Mattos-Ar
 @demattosarruda
٢٩ سبتمبر ٢٠١٩ م

Presidential session now: Monarch2 OS: 46 vs 37 m, fulvestran + or - abemaciclib —> median OS 9.4 months of benefit #ESMO19 #breastcancer #monarch2

demattosarruda's tweet image. Presidential session now: Monarch2 OS: 46 vs 37 m, fulvestran + or - abemaciclib —> median OS 9.4 months of benefit #ESMO19 #breastcancer #monarch2
0
1
4
0
0
LeCancerFr's profile picture. le #CANCER.fr site d'#ACTUALITÉ #santé scientifique en #ONCOLOGIE. #MÉDECINE #CLCC #CHU #CONGRÈS #CHIMIOTHÉRAPIE #IMMUNOTHÉRAPIE #oncology #ASCO #SABCS #ESMO
LeCancer.fr
@LeCancerFr
٤ يونيو ٢٠١٧ م

#ASCO2017 #SEIN #MONARCH2 #Resultats Arrivée de l’abemaciclib en combinaison au fulvestrant dans les cancers ... - bit.ly/2rSnbTe

LeCancerFr's tweet image. #ASCO2017 #SEIN #MONARCH2 #Resultats Arrivée de l’abemaciclib en combinaison au fulvestrant dans les cancers ... - bit.ly/2rSnbTe
0
0
1
0
0

Something went wrong.


Something went wrong.


United States Trends